TL;DR: Aetna, a CVS Health company, modified CPB 0676 — its electrical stimulation coverage policy for nausea, vomiting, and motion sickness — effective October 8, 2025. Here's what billing teams need to know before claims start hitting the wall.
This update to CPB 0676 Aetna tightens the line between covered and non-covered uses of transcutaneous electrical acupoint stimulation (TEAS) devices like PrimaBella and ReliefBand. The policy now names over 25 specific indications as experimental or investigational — a long list that will catch billing teams off guard if they haven't updated their charge capture. Primary codes affected include CPT 0783T for transcutaneous auricular neurostimulation setup, CPT 97813 for acupuncture with electrical stimulation (initial 15 minutes), and add-on CPT 97814 for each additional 15 minutes.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Electrical Stimulation for Nausea, Vomiting and Motion Sickness (PrimaBella and ReliefBand) and Other Selected Indications |
| Policy Code | CPB 0676 |
| Change Type | Modified |
| Effective Date | October 8, 2025 |
| Impact Level | Medium — narrow covered criteria, broad experimental exclusions |
| Specialties Affected | Oncology, OB/GYN, anesthesiology, surgery, neurology, pain management |
| Key Action | Audit all TEAS claims billed to Aetna and confirm the indication meets medical necessity criteria before October 8, 2025 |
Aetna Electrical Stimulation Coverage Criteria and Medical Necessity Requirements 2025
The Aetna electrical stimulation coverage policy under CPB 0676 covers two device types — ReliefBand and PrimaBella — but only in specific prescription versions and only for specific diagnoses. The over-the-counter version of ReliefBand doesn't qualify. Full stop.
Here's exactly what meets medical necessity under this policy:
ReliefBand (prescription version only):
| # | Covered Indication |
|---|---|
| 1 | Post-operative nausea — but only when antiemetics and other conservative therapies have already failed |
| 2 | Chemotherapy-induced nausea — same requirement: the patient must have tried and failed antiemetics first |
PrimaBella or ReliefBand (prescription version only):
| # | Covered Indication |
|---|---|
| 1 | Hyperemesis gravidarum — only when conservative therapy has failed (diet changes, ginger capsules, vitamin B6) |
That's the entire covered universe for this policy. Three indications. Both require documented failure of prior treatments — which means your clinical documentation needs to show the treatment progression before Aetna will consider reimbursement.
When billing CPT 97813 (initial 15-minute acupuncture with electrical stimulation) or CPT 97814 (each additional 15 minutes), the diagnosis code must map cleanly to one of those three covered indications. If the ICD-10 on the claim points to anything outside that list, expect a claim denial.
Prior authorization requirements aren't explicitly called out in the current CPB 0676 text, but given the "unresponsive to prior therapy" language, Aetna reviewers will look for step therapy documentation in medical records. Treat this like it requires prior authorization in practice — document the conservative therapy failure before ordering the device.
Aetna Electrical Stimulation Exclusions and Non-Covered Indications
This is where the policy gets long. Aetna lists more than 25 specific uses of TEAS, transcutaneous auricular neurostimulation, and related technologies as experimental, investigational, or unproven. The coverage policy is explicit: these won't pay.
The pattern here mirrors how Aetna handles other neuromodulation policies — a tight, evidence-based covered set surrounded by a broad experimental exclusion list. If you bill for any of these, you're looking at a claim denial.
The experimental designation applies to:
| # | Excluded Procedure |
|---|---|
| 1 | Combined magnetic ball compression with TEAS for post-operative nausea in gynecological laparoscopic surgery |
| 2 | CPT 0783T (Sparrow Ascent transcutaneous auricular neurostimulation) for opioid withdrawal relief |
| 3 | TEAS for cerebral palsy motor function improvement in children |
| 4 | TEAS for IVF pregnancy rate improvement |
| 5 | TEAS for post-operative stress response, delirium, or recovery quality |
| 6 | TEAS for gynecological laparoscopic surgery recovery |
| 7 | TEAS for sleep quality and analgesia after video-assisted thoracoscopic surgery (VATS — CPT codes 32601–32674) |
| 8 | TEAS for dysmenorrhea |
| 9 | TEAS for post-operative analgesia after radical mastectomy (CPT 19305, 19306, 19307) |
| 10 | TEAS for catheter-related bladder discomfort after transurethral prostate resection |
| 11 | TEAS for autonomic balance in heart transplant recipients |
| 12 | TEAS for motion sickness prevention |
| 13 | TEAS for post-operative urinary retention prevention |
| 14 | TEAS for etomidate-induced myoclonus reduction |
| 15 | TEAS for autism treatment |
| 16 | TEAS for cancer-induced bone pain |
| 17 | TEAS for chronic fatigue syndrome |
| 18 | TEAS for COPD |
| 19 | TEAS for hemodialysis-associated fatigue |
| 20 | TEAS for hypertension |
| 21 | TEAS for male infertility |
| 22 | TEAS for muscle spasticity after brain injury |
| 23 | TEAS for pain after total knee arthroplasty |
| 24 | TEAS for post-hemorrhoidectomy pain and anxiety |
| 25 | TEAS for post-operative immune dysfunction in lung cancer |
| 26 | TEAS for post-operative GI dysfunction in colorectal or gastric cancer |
| 27 | TEAS for PTSD |
| 28 | TEAS for tinnitus |
| 29 | Transcutaneous auricular vagus nerve stimulation for epilepsy or motion sickness |
| 30 | Transcutaneous neuromodulation and auricular electrostimulation for nausea, vomiting, or motion sickness outside covered criteria |
| 31 | Trans-auricular electrical stimulation for motion sickness |
That last point matters: motion sickness is specifically excluded across multiple device categories and modalities. Billing for motion sickness under any formulation — OTC or prescription, TEAS or auricular — will not get paid under this coverage policy.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Post-operative nausea (prescription ReliefBand) | Covered | CPT 97813, 97814 | Must fail antiemetics and conservative therapy first |
| Chemotherapy-induced nausea (prescription ReliefBand) | Covered | CPT 97813, 97814 | Must fail antiemetics and conservative therapy first |
| Hyperemesis gravidarum (prescription PrimaBella or ReliefBand) | Covered | CPT 97813, 97814 | Must fail diet change, ginger, vitamin B6 first |
| Motion sickness prevention (any TEAS device) | Not Covered / Experimental | — | Excluded across all device types including OTC ReliefBand |
| OTC ReliefBand (any indication) | Not Covered | — | Does not meet Aetna's DME definition |
| Opioid withdrawal (Sparrow Ascent, CPT 0783T) | Experimental | CPT 0783T | Transcutaneous auricular neurostimulation — no coverage |
| Post-op nausea in gynecological laparoscopy (combined magnetic ball + TEAS) | Experimental | CPT 97813, 97814 | Combination approach not covered |
| VATS post-op sleep/analgesia | Experimental | CPT 32601–32674 | All thoracoscopy VATS codes referenced |
| Post-mastectomy analgesia | Experimental | CPT 19305, 19306, 19307 | All three mastectomy code variants |
| Dysmenorrhea | Experimental | — | No covered formulation |
| Autism treatment | Experimental | — | No covered formulation |
| Chronic fatigue, COPD, hemodialysis fatigue | Experimental | — | No covered formulation |
| Hypertension, male infertility | Experimental | — | No covered formulation |
| PTSD, tinnitus | Experimental | — | No covered formulation |
| Epilepsy (auricular vagus nerve stimulation) | Experimental | — | Transcutaneous auricular vagus nerve stim not covered |
| Cancer-induced bone pain | Experimental | — | No covered formulation |
| Post-op urinary retention prevention | Experimental | — | No covered formulation |
| Total knee arthroplasty pain | Experimental | — | No covered formulation |
| Cerebral palsy (children) | Experimental | — | No covered formulation |
| IVF pregnancy rates | Experimental | — | No covered formulation |
| Heart transplant autonomic modulation | Experimental | — | No covered formulation |
Aetna Electrical Stimulation Billing Guidelines and Action Items 2025
The effective date is October 8, 2025. That gives your billing team time to fix things before denied claims pile up. Here's what to do.
| # | Action Item |
|---|---|
| 1 | Audit your active TEAS claims for Aetna members now. Pull any claims billed with CPT 97813 or 97814 linked to Aetna. Check every ICD-10 on those claims. If the diagnosis isn't post-op nausea, chemo-induced nausea, or hyperemesis gravidarum — you have a problem to fix before October 8, 2025. |
| 2 | Remove OTC ReliefBand from your charge capture entirely for Aetna patients. Aetna does not consider the over-the-counter disposable ReliefBand to be durable medical equipment. Claims for it will not pay. This isn't a prior authorization issue — it's a flat exclusion. |
| 3 | Build documentation requirements into your order workflow for covered indications. For post-op nausea and chemo-induced nausea, the chart must show prior antiemetic failure. For hyperemesis gravidarum, document that diet modification, ginger capsules, and vitamin B6 were tried first. Without that documentation, medical necessity reviews will go against you. |
| 4 | Flag CPT 0783T (Sparrow Ascent) as non-covered for Aetna. If your team bills 0783T for opioid withdrawal relief, stop. This policy explicitly designates it experimental. Build a payer-specific billing rule that blocks 0783T on Aetna claims before they go out. |
| 5 | Brief your oncology and OB/GYN billing teams on the mastectomy and VATS exclusions. If your surgeons order TEAS adjuncts for post-mastectomy pain (CPT 19305, 19306, 19307) or post-VATS sleep and analgesia (CPT 32601–32674), those won't reimburse under Aetna. Educate your clinical teams so they set accurate patient expectations upfront. |
| 6 | Talk to your compliance officer if you have significant claim volume in the experimental indications. Twenty-five-plus experimental indications is a long list. If your practice bills across multiple of those areas, you need an internal review before October 8, 2025 — not after your first denial round. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Electrical Stimulation Under CPB 0676
Covered CPT Codes (When Medical Necessity Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 97813 | CPT | Acupuncture with electrical stimulation, initial 15 minutes of personal one-on-one contact |
| +97814 | CPT | Acupuncture with electrical stimulation, each additional 15 minutes of personal one-on-one contact |
Not Covered / Experimental CPT Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0783T | CPT | Transcutaneous auricular neurostimulation, set-up, calibration, and patient education | Experimental — Sparrow Ascent for opioid withdrawal; combined magnetic ball + TEAS indications |
| 97813 | CPT | Acupuncture with electrical stimulation, initial 15 minutes | Experimental when billed for non-covered indications (see exclusion list above) |
| +97814 | CPT | Acupuncture with electrical stimulation, each additional 15 minutes | Experimental when billed for non-covered indications |
| 19305 | CPT | Mastectomy, radical, including pectoral muscles, axillary lymph nodes | Referenced in experimental context — TEAS for post-mastectomy analgesia not covered |
| 19306 | CPT | Mastectomy, radical, including pectoral muscles, axillary and internal mammary lymph nodes | Referenced in experimental context |
| 19307 | CPT | Mastectomy, modified radical, including axillary lymph nodes | Referenced in experimental context |
| 32601–32674 | CPT | Thoracoscopy/VATS (full range) | Referenced in experimental context — TEAS for post-VATS sleep quality and analgesia not covered |
Note: The VATS CPT code range in the policy data spans CPT 32601 through 32674. All thoracoscopy codes in that range are referenced in the experimental/non-covered group for TEAS analgesia and sleep quality indications.
HCPCS Codes
The policy data for CPB 0676 does not list specific covered HCPCS codes. The OTC ReliefBand device is explicitly excluded from DME coverage — no HCPCS code will generate reimbursement for it under this policy.
Key ICD-10-CM Diagnosis Codes
The policy references 252 ICD-10-CM codes in its full code set. The specific codes in the provided data excerpt are not individually listed, but the clinical indications that map to covered diagnoses include:
- Post-operative nausea and vomiting
- Chemotherapy-induced nausea and vomiting
- Hyperemesis gravidarum
Work with your coding team to confirm ICD-10 codes from the full CPB 0676 code list at app.payerpolicy.org/p/aetna/0676. Using an unsupported ICD-10 is the fastest path to a claim denial under this policy.
Get the Full Picture for CPT 97813
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.